Compound
Retatrutide
Everything in the archive that discusses Retatrutide in substance — with sources and context.
2 matching articles
Research · 31 August 2026 · 14 min read
What Is Retatrutide? Mechanism, Phase 3 Results and Approval Status
Retatrutide (LY3437943) is an investigational triple hormone receptor agonist at the GIP, GLP-1 and glucagon receptors. What the peer-reviewed trials show, how the 2026 topline Phase 3 results should be read, and why it is approved nowhere.
Research · 26 August 2026 · 8 min read
Reconstitution Math: From Vial Label to an Accurate Volume
Most dosing error in peptide work is arithmetic, not chemistry. How diluent volume, syringe units and net peptide content interact — and the three places the calculation usually breaks.